Cytek Biosciences, Inc. Overview
Pro stress-test →Cytek Biosciences is a cell analysis solutions company that provides cell analysis tools facilitating scientific advances in biomedical research and clinical applications. The company focuses on delivering high-resolution, high-content and high-sensitivity cell analysis using its patented Full Spectrum Profiling™ (FSP®) technology.
Strategic Profile
Pro stress-test →The FSP platform addresses limitations of other technologies by providing higher-density information with greater sensitivity, more flexibility and increased efficiency. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations, with direct sales force and support in North America, Europe, China, and Asia-Pacific regions.
Competitive Landscape
Pro stress-test →Competitors include Imperial Life Sciences, TerumoBCT, Active Motif, Treefrog Therapeutics, and FluoroFinder. Cytek faces competition from legacy providers and must navigate complex regulatory environments to secure clinical certifications.
Industry Context
Cytek Biosciences, Inc. operates in Analytical Laboratory Instrument Manufacturing / Life Sciences Technology / Flow Cytometry.
Key facts
Founded: 1992 · Headquarters: Fremont, US · Revenue: $200.45M (2024) · Market cap: $640.6M